You have vertigo, but your inner ear is fine. Here's why.

MTHFR encodes an enzyme responsible for converting folate into its active form, methylfolate. This active form is critical for producing methionine, which drives the methylation cycle. The methylation cycle regulates homocysteine levels. Homocysteine is a marker of methylation efficiency, and elevated homocysteine damages small blood vessels throughout your body, including the delicate capillaries that feed your inner ear and vestibular nerve.

The MTHFR C677T variant, present in roughly 40% of people with European ancestry, reduces enzyme efficiency by 40 to 70%. That means even if you’re eating folate-rich foods and taking standard folic acid supplements, your cells are struggling to convert them into the active form your body actually needs. You can have normal folate levels on a blood test and still have functionally depleted methylation at the cellular level.

When your inner ear blood supply is compromised, vertigo is often the first symptom you notice. The vestibular system is exquisitely sensitive to oxygen fluctuations. Restricted blood flow triggers dizziness, imbalance, and spatial disorientation. If your MTHFR variant is driving elevated homocysteine, standard vestibular therapy alone won’t fix the underlying vascular problem.

NOS3 encodes endothelial nitric oxide synthase, the enzyme that produces nitric oxide in your blood vessel linings. Nitric oxide is a master signaling molecule that dilates blood vessels, reduces inflammation, and ensures adequate blood flow to every tissue, including your inner ear and the parts of your brain that control balance.

The Glu298Asp variant in NOS3 is carried by roughly 30 to 40% of the population. People with this variant produce less functional nitric oxide, meaning their blood vessels are chronically under-dilated. Your cerebral and cochlear circulation operates at a reduced baseline, making you more vulnerable to dizziness whenever blood flow demands increase or fluctuate.

You notice this most during position changes, after exertion, during stress, or in hot environments. These are the moments when nitric oxide is supposed to kick in and adjust blood flow dynamically. If your NOS3 variant impairs that response, your brain and inner ear don’t get the blood flow adjustment they need, and vertigo results.

CACNA1A encodes the primary calcium channel in the cerebellum and vestibular nuclei. These structures are your brain’s central balance coordinators. Calcium flow through these channels is how neurons communicate balance-related signals in millisecond precision. Without proper calcium signaling, your brain receives garbled or delayed balance information.

Variants in CACNA1A are less common than MTHFR or NOS3 variants, affecting roughly 1 to 5% of people with familial vestibular disorders, but when present they have outsized impact. A dysfunctional CACNA1A variant can cause episodic vertigo that feels like the classic inner ear attacks but occurs for entirely different neurological reasons. The attacks may come on suddenly, last hours or days, and respond poorly to standard vestibular treatments.

You experience this as sudden spinning sensations, difficulty coordinating your eyes with head movement, or a sense that your body doesn’t know where it is in space. Unlike mechanical inner ear problems, CACNA1A-related vertigo often improves with specific neurological support rather than physical therapy alone.

COMT encodes catechol-O-methyltransferase, an enzyme that breaks down dopamine in your prefrontal cortex and other brain regions. The rate at which you clear dopamine affects how effectively your brain processes sensory information, including balance signals. Dopamine is also central to the basal ganglia and cerebellar circuits that fine-tune coordinated movement and spatial orientation.

The Val158Met variant is present in roughly 25% of people as a homozygous slow-metabolizer genotype. Slow COMT means dopamine accumulates in your synapses longer, creating a state of relative dopamine excess in some tissues and relative deficit in others. Slow COMT can exacerbate dizziness by destabilizing the balance between excitatory and inhibitory signaling in your vestibular processing centers.

You may notice your vertigo or dizziness is worse when you’re stressed, after caffeine intake, or in situations with high sensory input. Dopamine dysregulation makes your vestibular system hyperresponsive to stimuli that shouldn’t cause problems.

VDR encodes the vitamin D receptor, a nuclear receptor that controls how your cells respond to active vitamin D (calcitriol). Vitamin D signaling is critical throughout your vestibular system, both for calcium homeostasis in the inner ear and for immune regulation that prevents inflammatory damage to the vestibular nerve.

Common VDR variants like FokI, BsmI, and ApaI are present in roughly 30 to 50% of the population depending on ancestry. Certain VDR variants create a state of relative vitamin D resistance, where even high serum vitamin D levels don’t translate into robust cellular signaling at the vestibular level. This leaves your inner ear more vulnerable to inflammation and less able to maintain proper calcium balance in the endolymph, the fluid inside your vestibular organs.

You experience this as intermittent dizziness, sensitivity to loud sounds, and vertigo that worsens during viral illnesses or inflammatory flares. Your inner ear is essentially operating without the protective immune-regulatory benefit of vitamin D signaling.

SLC6A4 encodes the serotonin transporter, the protein that recycles serotonin back into neurons after it’s been released into the synapse. The efficiency of this recycling determines how long serotonin lingers in your synapses and how effectively your brain’s serotonin signaling works. Serotonin is deeply involved in vestibular function, particularly in the dorsal raphe nucleus projections to the vestibular nuclei.

The 5-HTTLPR short allele is carried by roughly 40% of the population, and people with at least one short allele have reduced serotonin transporter expression. This means serotonin accumulates in your vestibular synapses, creating a state of chronic serotonin excess that can destabilize balance signaling and paradoxically increase dizziness sensitivity. This is particularly pronounced if you’re also taking SSRIs or eating high amounts of tryptophan-rich foods.

You may notice your dizziness fluctuates with mood, stress, or seasonal changes, or that it worsened when you started an antidepressant despite the medication helping your mood. Your vestibular system is exquisitely sensitive to serotonin tone.